机构:[a]Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province,[b]Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province,[c]Collaborative Innovation Center of Chinese Medicines from Zhejiang Province,[d]College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, People’s Republic of China.[e]School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510000, People’s Republic of China.[f]Department of Basic Medicine, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, People’s Republic of China.[g]INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.[h]Université de Bourgogne-Franche Comté, I-SITE, France.[i]University Hospital of Dijon (CHU). jAnti-cancer Center George-François Leclerc, CGFL, Dijon, France
This work was funded by the National Natural Science Foundation of China (81730108 and
81973635), Hangzhou Normal University startup fund (4125C5021920419), Hangzhou Normal
University, School of Medicine Teaching Reform Fund (4125b30100112), Project of National
Students’ Platform for Innovation and Entrepreneurship Training Program (201810346040,
201910346035), Program of “Xin miao” Talents in Zhejiang Province of China (2019R426040).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类|2 区医学
小类|2 区药学
最新[2025]版:
大类|2 区医学
小类|2 区药学
第一作者:
第一作者机构:[a]Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province,[b]Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province,[c]Collaborative Innovation Center of Chinese Medicines from Zhejiang Province,[d]College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, People’s Republic of China.[e]School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510000, People’s Republic of China.
通讯作者:
通讯机构:[a]Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province,[b]Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province,[c]Collaborative Innovation Center of Chinese Medicines from Zhejiang Province,[d]College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, People’s Republic of China.[g]INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.[h]Université de Bourgogne-Franche Comté, I-SITE, France.
推荐引用方式(GB/T 7714):
Yuan Gao,Hang Zhang,Frédéric Lirussi,et al.Dual inhibitors of Histone Deacetylases and Other Cancer-Related Targets: A Pharmacological Perspective.[J].Biochemical pharmacology.2020,182:114224.doi:10.1016/j.bcp.2020.114224.
APA:
Yuan Gao,Hang Zhang,Frédéric Lirussi,Carmen Garrido,Xiang-YangYe&Tian Xie.(2020).Dual inhibitors of Histone Deacetylases and Other Cancer-Related Targets: A Pharmacological Perspective..Biochemical pharmacology,182,
MLA:
Yuan Gao,et al."Dual inhibitors of Histone Deacetylases and Other Cancer-Related Targets: A Pharmacological Perspective.".Biochemical pharmacology 182.(2020):114224